MAQUET CARDIOVASCULAR acquires LAAX Inc. and its TIGERPAW® SYSTEM II Occlusion Device to expand cardiac surgery offering.

Maquet and Richard Wolf announced today a non-exclusive sales cooperation on a regional level. By joining forces, both companies will be in the unique position to offer complete, efficient and high-quality OR integration solutions for endoscopy.

Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, announced today that it plans to relocate its company headquarters to a newly purchased site in Merrimack, NH to accommodate the company's exponential growth over the last few years.

Study to evaluate endothelial function of grafts in patients undergoing coronary artery bypass graft surgery.

Maquet announces that Siemens Healthcare will integrate Maquet’s operating table Magnus in its Artis zeego and Artis zee ceiling interventional systems.

Next generation ACROBAT-i Stabilizer and Positioner System improves visibility and control for off-pump coronary artery bypass graft patients.

Resulting Article Details Gold Standard Technology Advancements and Procedure
Techniques to Help Optimize Long-term Graft Quality

OPTION Trial:  Designed to Address Conduit Quality of Endoscopically Harvested Grafts Obtained Using Optimal Technologies and Procedure Protocols

Helps Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients - Syringe Protects Vessels from Overdistension and Potential Endothelial Damage During Standard Surgical Preparation Steps

HEARTSTRING Proximal Seal System Reduces the Risk for Neurological Complications During Coronoary Artery Bypass Grafting

Use of Minimally Invasive VASOVIEW System Decreases Risk of Leg Wound Infection While Providing Clinical Outcomes Comparable to Traditional Vein Harvesting Procedure - published in January 2010 Annals of Thoracic Surgery

– Data Demonstrate Equivalent Early- and Long-Term Graft Patency and Event-Free Survival with OPCAB and Conventional On-Pump Coronary Artery Bypass Surgery –

 – OPTION Trial Designed to Address Conduit Quality of Endoscopically-Harvested Grafts Using Optimal Technologies and Procedure Protocols –

References study findings presented by Doctor Robert Poston at ISMICS Meeting June 5, 2009 covering the positive effects of heparin administration prior to EVH in terms of limiting clot retention and improving graft patency.

Bridgewater, NJ (July 21, 2008) — MAQUET, Inc. announced the commercial
release of new LED surgical lights – the PowerLED 700 and the compact
PowerLED 500 – incorporating the latest LED technology for significant
improvements in illumination and ease of use.

MAQUET has won a $ 12,5 million order in a recently conducted bid for a contract by Rio de Janeiro State Health Authority. The company will deliver 310 of its SERVO-s ventilators to 25 hospitals in the the region during May 2008.

Getinge significantly expands in area of cardiac and vascular surgery, and creating platform for new growth.

BRIDGEWATER, NJ (September 20, 2007) – MAQUET, a leading developer, manufacturer and distributor of innovative medical devices – has announced the appointment of Steven Greenfield as Vice President of Critical Care Sales. Greenfield will be responsible for managing the critical care division’s U.S. organization of sales representatives.

BRIDGEWATER, NJ (September 26, 2007) – MAQUET, a leading developer, manufacturer and distributor of innovative medical devices – will be named Vendor of the Year by the New Jersey Society for Respiratory Care (NJSRC) on October 4, 2007 in Atlantic City, New Jersey. This will be the second Vendor of the Year award received by MAQUET.

MAQUET Critical Care announces that they have received FDA 510(k) clearance for an upgrade of its SERVO-i Ventilator System for conditional use in the magnetic resonance (MR) environment. The SERVO-i ventilator is intended for treatment and monitoring of all patients—neonatal, pediatric and adults—who require mechanical ventilation.

MAQUET Critical Care announces that they have received FDA 510(k) clearance to its breakthrough NAVA (Neurally Adjusted Ventilatory Assist) technology for optional use with the company’s SERVO-i ventilator. The SERVO-i ventilator with NAVA option is intended for treatment and monitoring of all patients, neonatal, pediatric, and adults who require mechanical ventilation.

MAQUET, a German global market leader for operating room systems and Intensive Care Units launches a regional sales office in Dubai, participates in Arab health exhibition with a 168 square metre Stand

MAQUET to inaugurate its Middle East office in Dubai on the 28^th of January.

MAQUET do Brasil Ltda. is now integrating the MAQUET Cardiopulmonary business. MAQUET do Brasil Ltda. has acquired 75% of the shares of the company Comercio e Industria Medica Ltda. This newly founded company is named MAQUET Cardio-pulmonary do Brasil Ltda.

Cognos (NASDAQ: COGN; TSX: CSN), the leading provider of business intelligence and performance management solutions, today announced that MAQUET GmbH & Co. KG has deployed a performance management solution for improved sales planning. With the Cognos solution, the international medical technology provider is updating the technology foundation for its Medical Systems business and is optimizing its production processes. Shorter planning cycles coupled with ongoing, detailed evaluation of all relevant data will ensure a competitive edge for MAQUET, allowing it to further extend its position as the quality leader.